These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33902495)

  • 1. Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma.
    Wang JY; Wang XK; Zhu GZ; Zhou X; Yao J; Ma XP; Wang B; Peng T
    BMC Cancer; 2021 Apr; 21(1):462. PubMed ID: 33902495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.
    Yao M; Yao DF; Bian YZ; Wu W; Yan XD; Yu DD; Qiu LW; Yang JL; Zhang HJ; Sai WL; Chen J
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):171-9. PubMed ID: 23558072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma.
    Wang L; Yao M; Pan LH; Qian Q; Yao DF
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):361-6. PubMed ID: 26256079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.
    Yao M; Yao DF; Bian YZ; Zhang CG; Qiu LW; Wu W; Sai WL; Yang JL; Zhang HJ
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):289-94. PubMed ID: 21669573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma.
    Wang L; Pan L; Yao M; Cai Y; Dong Z; Yao D
    Oncotarget; 2016 Jul; 7(27):42150-42158. PubMed ID: 27286460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
    Feng J; Zhu R; Chang C; Yu L; Cao F; Zhu G; Chen F; Xia H; Lv F; Zhang S; Sun L
    PLoS One; 2016; 11(3):e0151501. PubMed ID: 26977595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation.
    Cui X; Li Z; Gao PJ; Gao J; Zhu JY
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):157-63. PubMed ID: 25865688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation.
    Wang YL; Zhu ZJ; Teng DH; Yao Z; Gao W; Shen ZY
    World J Gastroenterol; 2012 May; 18(19):2408-14. PubMed ID: 22654434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic significance of mRNA expressions of apolipoprotein A and C family genes in hepatitis B virus-related hepatocellular carcinoma.
    Wang X; Gong Y; Deng T; Zhang L; Liao X; Han C; Yang C; Huang J; Wang Q; Song X; Zhang T; Yu T; Zhu G; Ye X; Peng T
    J Cell Biochem; 2019 Oct; 120(10):18246-18265. PubMed ID: 31211449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulating glypican-3 expression: molecular-targeted therapy for hepatocellular carcinoma.
    Dong Z; Yao M; Wang L; Yang J; Yao D
    Mini Rev Med Chem; 2014; 14(14):1183-93. PubMed ID: 25553423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-cancer analysis and the oncogenic role of Glypican 1 in hepatocellular carcinoma.
    Cao L; Li F; Cai S; Zhang J; Guo C; Ali S; Zhou J; Jing X; Wang X; Qin Y; Wu F
    Sci Rep; 2024 Jul; 14(1):15870. PubMed ID: 38982153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
    Li J; Gao JZ; Du JL; Wei LX
    World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis.
    Xiao WK; Qi CY; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
    BMC Cancer; 2014 Feb; 14():104. PubMed ID: 24548704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
    Wang Y; Huang Q; Deng T; Li BH; Ren XQ
    Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
    Jiang W; Wu T; Shi X; Xu J
    Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
    Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
    Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression features of glypican-3 and its diagnostic and differential values in hepatocellular carcinoma].
    Bian YZ; Yao DF; Zhang CG; Li SS; Wu W; Dong ZZ; Qiu LW; Yu DD
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):260-5. PubMed ID: 21586223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.